Loading clinical trials...
Loading clinical trials...
Due to the scarcity of data on prognostic and predictive influence on CCA, epidemiological studies evaluating these factors need to be developed in patients with CCA. Therefore, the investigators want...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Latin American Cooperative Oncology Group
NCT06694805 · HIV Infections
NCT07217171 · Bladder Cancer, Squamous Cell Carcinoma of the Lung, and more
NCT06627764 · Substance Abuse, Intimate Partner Violence (IPV), and more
NCT04142047 · HIV, HIV Infections
NCT06050707 · Anal Squamous Cell Carcinoma
A.C. Camargo Cancer Center
São Paulo
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions